Registrars Coding the Future: Precision Medicine 2.0
The presenters will delve into the connections between precision medicine and cancer registry abstracting. They will discuss the important roles genetics and tumor profiling have on the work of cancer registrars and review the targeted therapies that are affected.
Learning Objectives:
Understand the role of genetics and tumor profiling. Explain various testing platforms and review targeted therapies. Review patient outcomes and survival.
Credit Information
Activity Number
Credit Amount
Accreditation Period
2022-140
1 CE
October 12, 2022 - October 05, 2025
Instructors
Joe Burkhart, BS, RHIA, CTR
Instructor
Joe Burkhart is the Senior Manager Clinical Abstraction for Syapse. Burkhart is responsible for all new-hire training, training of core data elements, and the coordination of health system access for all clinical abstractors. He manages subject-spotlight cohorts within clinical abstraction and provides leadership and support to other cohort managers.
Ronda Broome, MSHMI, MS, ODS-C
Instructor
Ronda Broome serves as the Associate Director of Clinical Abstraction at Syapse, a healthcare technology company dedicated to extinguishing the fear and burden of serious disease by advancing real-world care. She combines an exceptional ability to foster positive relationships with providers and teams with her leadership prowess and vibrant energy. Broome holds an MS in Biology/Bioinformatics from Georgia State University and an MS in Healthcare Management and Informatics from Kennesaw State University. She dedicates her time to volunteering with the Georgia Tumor Registrars Association and NCRA. Broome is the chair of NCRA’s National Cancer Registrars Week (NCRW) Committee and serves as an active member of several other NCRA committees, including Informatics, Ethics, and Membership.
Other products with this instructor
